NCT06101134 2026-04-09A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose CombinationsBristol-Myers SquibbPhase 2 Active not recruiting100 enrolled 11 charts
NCT06046625 2025-04-04Needs and Preferences of Patients With Head-neck Cutaneous SCCMaastricht University Medical CenterActive not recruiting15 enrolled
NCT05883956 2025-03-20PREFER-HMAOtsuka Australia Pharmaceutical Pty LtdPhase 3 Active not recruiting13 enrolled